NOT-HL-20-792: NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-19-329 and PAR-19-330: Multi-Site Investigator-Initiated Clinical Trials

NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-19-329 and PAR-19-330: Multi-Site Investigator-Initiated Clinical Trials

Notice Number:

NOT-HL-20-792

Key Dates

Release Date:

May 19, 2020

Related Announcements

PAR-19-329: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

PAR-19-330: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that NHLBI has posted a set of responses to Frequently Asked Questions (FAQs) regarding Multi-Site Investigator-Initiated Clinical Trials for PAR-19-329: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) and PAR-19-330: Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required). The FAQs are available on the NHLBI website at the following link: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities/foa-Investigator-Initiated-Multi-Site-Clinical-Trials-FAQ.
Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Division of Blood Diseases and Resources
Nancy DiFronzo, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0065
Email: difronzon@nhlbi.nih.gov

Division of Cardiovascular Sciences
Yves Rosenberg, MD, MPH
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0550
Email: rosenbey@nhlbi.nih.gov

Division of Lung Diseases
Gail Weinmann, MD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0233
Email: weinmang@nhlbi.nih.gov

Peer Review Contact(s)

Keary A. Cope, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0287
Email: copeka@nhlbi.nih.gov

Financial/Grants Management Contact(s)

Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8014
Email: agrestia@nhlbi.nih.gov